What Happened?
Wayne, PA-based Aclaris Therapeutics Appointed Meghan Dunsmore as Senior Director, Finance and Corporate Controller
About the Company
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.
About the Person
Meghan Dunsmore is Senior Director, Finance and Corporate Controller at Aclaris Therapeutics. Previously, Meghan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile